• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53调控人类拓扑异构酶IIα基因的最小启动子。

p53 regulates the minimal promoter of the human topoisomerase IIalpha gene.

作者信息

Sandri M I, Isaacs R J, Ongkeko W M, Harris A L, Hickson I D, Broggini M, Vikhanskaya F

机构信息

Imperial Cancer Research Fund, University of Oxford, John Radcliffe Hospital, UK.

出版信息

Nucleic Acids Res. 1996 Nov 15;24(22):4464-70. doi: 10.1093/nar/24.22.4464.

DOI:10.1093/nar/24.22.4464
PMID:8948636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC146283/
Abstract

DNA topoisomerase IIalpha is an essential enzyme for chromosome segregation during mitosis. Consistent with a cell division-specific role, the expression of the topoisomerase IIalpha gene is strongly influenced by the proliferation status of cells. The p53 protein is one of the most important regulators of cell cycle progression in mammals, with an apparent dual role in the induction of cell cycle arrest following cytotoxic insults and in the regulation of the apoptotic cell death pathway. We have analysed whether p53 plays a role in regulating expression of the human topoisomerase IIalpha gene. We show that wild-type, but not mutant, p53 is able to decrease substantially the activity of the full length topoisomerase IIalpha gene promoter. Using a series of constructs comprising various deleted or mutated versions of the promoter lacking critical cis-acting elements, we show that this p53-specific regulation of the topoisomerase IIalpha promoter is independent of all characterised transcription factor binding sites and is directed at the minimal gene promoter. We conclude that expression of wild-type p53 induces downregulation of the human topoisomerase IIalpha promoter by acting on the basal transcription machinery. These findings implicate topoisomerase II as one of the downstream targets for p53-dependent regulation of cell cycle progression in human cells.

摘要

DNA拓扑异构酶IIα是有丝分裂期间染色体分离所必需的酶。与细胞分裂特异性作用一致,拓扑异构酶IIα基因的表达受到细胞增殖状态的强烈影响。p53蛋白是哺乳动物细胞周期进程最重要的调节因子之一,在细胞毒性损伤后诱导细胞周期停滞以及调节凋亡性细胞死亡途径中具有明显的双重作用。我们分析了p53是否在调节人类拓扑异构酶IIα基因的表达中发挥作用。我们发现野生型而非突变型p53能够大幅降低全长拓扑异构酶IIα基因启动子的活性。使用一系列包含缺乏关键顺式作用元件的启动子的各种缺失或突变版本的构建体,我们表明拓扑异构酶IIα启动子的这种p53特异性调节独立于所有已鉴定的转录因子结合位点,并且针对最小基因启动子。我们得出结论,野生型p53的表达通过作用于基础转录机制诱导人类拓扑异构酶IIα启动子的下调。这些发现表明拓扑异构酶II是人类细胞中p53依赖性细胞周期进程调节的下游靶点之一。

相似文献

1
p53 regulates the minimal promoter of the human topoisomerase IIalpha gene.p53调控人类拓扑异构酶IIα基因的最小启动子。
Nucleic Acids Res. 1996 Nov 15;24(22):4464-70. doi: 10.1093/nar/24.22.4464.
2
Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter.Sp1介导大鼠DNA拓扑异构酶IIα基因启动子的细胞增殖依赖性调控。
Biochem J. 1999 Dec 1;344 Pt 2(Pt 2):367-74.
3
Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.核因子Y与拓扑异构酶IIα启动子的结合受到p53肿瘤抑制因子和抗癌药物的双重抑制。
Mol Pharmacol. 2003 Feb;63(2):359-67. doi: 10.1124/mol.63.2.359.
4
Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.汇合生长停滞细胞中人类拓扑异构酶IIα基因启动子的调控
J Biol Chem. 1996 Jul 12;271(28):16741-7. doi: 10.1074/jbc.271.28.16741.
5
Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.耐药细胞系中参与拓扑异构酶IIα表达下调的启动子元件的表征
Gene. 2004 Nov 10;342(1):145-55. doi: 10.1016/j.gene.2004.07.033.
6
p53 modulation of DNA topoisomerase IIalpha gene expression.p53对DNA拓扑异构酶IIα基因表达的调控
Cell Biochem Biophys. 2000;33(2):209-16. doi: 10.1385/cbb:33:2:209.
7
Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIalpha and beta in various human cancer cell lines.野生型p53表达对多种人类癌细胞系中拓扑异构酶IIα和β的数量及活性的影响。
J Cell Biochem. 1999 Nov 1;75(2):245-57. doi: 10.1002/(sici)1097-4644(19991101)75:2<245::aid-jcb7>3.3.co;2-7.
8
The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.p53肿瘤抑制蛋白通过提高ATP水解速率来刺激人拓扑异构酶IIα的催化活性。
J Biol Chem. 2000 Jun 16;275(24):18503-10. doi: 10.1074/jbc.M002081200.
9
Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.p53肿瘤抑制因子对DNA拓扑异构酶IIα基因表达的抑制作用。
Mol Cell Biol. 1997 Jan;17(1):389-97. doi: 10.1128/MCB.17.1.389.
10
Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.DNA拓扑异构酶IIα启动子的细胞周期调控由近端CCAAT框介导:乙酰化可能参与其中。
Gene. 2000 Mar 7;245(1):49-57. doi: 10.1016/s0378-1119(00)00040-8.

引用本文的文献

1
The regulation of DNA supercoiling across evolution.DNA 超螺旋结构在进化中的调控。
Protein Sci. 2021 Oct;30(10):2042-2056. doi: 10.1002/pro.4171. Epub 2021 Aug 23.
2
The Rich World of p53 DNA Binding Targets: The Role of DNA Structure.p53 DNA 结合靶点的丰富世界:DNA 结构的作用。
Int J Mol Sci. 2019 Nov 9;20(22):5605. doi: 10.3390/ijms20225605.
3
Mutual regulation of MDM4 and TOP2A in cancer cell proliferation.MDM4 和 TOP2A 在癌细胞增殖中的相互调控。
Mol Oncol. 2019 May;13(5):1047-1058. doi: 10.1002/1878-0261.12457. Epub 2019 Feb 4.
4
A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models.临床前胶质瘤模型中拓扑异构酶抑制作用的系统评价与荟萃分析
Oncotarget. 2018 Jan 29;9(13):11387-11401. doi: 10.18632/oncotarget.24334. eCollection 2018 Feb 16.
5
PTEN stabilizes TOP2A and regulates the DNA decatenation.PTEN可稳定TOP2A并调节DNA解连环。
Sci Rep. 2015 Dec 10;5:17873. doi: 10.1038/srep17873.
6
Topo2A as a prognostic biomarker for patients with resectable esophageal squamous cell carcinomas.拓扑异构酶2A作为可切除食管鳞状细胞癌患者的预后生物标志物。
Med Oncol. 2015 Jan;32(1):396. doi: 10.1007/s12032-014-0396-7. Epub 2014 Nov 29.
7
Topoisomerase IIα in chromosome instability and personalized cancer therapy.染色体不稳定性与个性化癌症治疗中的拓扑异构酶IIα
Oncogene. 2015 Jul 30;34(31):4019-31. doi: 10.1038/onc.2014.332. Epub 2014 Oct 20.
8
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.高危早期乳腺癌患者接受辅助表阿霉素为基础的剂量密集序贯化疗后 HER2 和 TOP2A 状态。
J Transl Med. 2012 Jan 12;10:10. doi: 10.1186/1479-5876-10-10.
9
HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.高迁移率族蛋白B1(HMGB1)和高迁移率族蛋白B2(HMGB2)可上调人类拓扑异构酶IIα的细胞表达。
Nucleic Acids Res. 2009 Apr;37(7):2070-86. doi: 10.1093/nar/gkp067. Epub 2009 Feb 17.
10
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.拓扑异构酶-IIα在晚期卵巢癌患者中的预后作用
Br J Cancer. 2008 Jun 17;98(12):1910-5. doi: 10.1038/sj.bjc.6604410. Epub 2008 May 27.

本文引用的文献

1
Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.汇合生长停滞细胞中人类拓扑异构酶IIα基因启动子的调控
J Biol Chem. 1996 Jul 12;271(28):16741-7. doi: 10.1074/jbc.271.28.16741.
2
The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation.拓扑异构酶IIα在S期与细胞周期偶联的表达受mRNA稳定性调控,并受热休克或电离辐射破坏。
Mol Cell Biol. 1996 Apr;16(4):1500-8. doi: 10.1128/MCB.16.4.1500.
3
Regulation of the human hsp70 promoter by p53.p53对人类hsp70启动子的调控
Science. 1993 Jan 1;259(5091):84-7. doi: 10.1126/science.8418500.
4
Drug resistance associated with altered DNA topoisomerase II.与DNA拓扑异构酶II改变相关的耐药性。
Adv Enzyme Regul. 1993;33:113-27. doi: 10.1016/0065-2571(93)90012-3.
5
DNA topoisomerase I and II in cancer chemotherapy: update and perspectives.癌症化疗中的DNA拓扑异构酶I和II:最新进展与展望
Cancer Chemother Pharmacol. 1993;32(2):103-8. doi: 10.1007/BF00685611.
6
Novel HeLa topoisomerase II is the II beta isoform: complete coding sequence and homology with other type II topoisomerases.新型海拉细胞拓扑异构酶II是IIβ亚型:完整编码序列及其与其他II型拓扑异构酶的同源性。
Biochim Biophys Acta. 1993 Mar 20;1172(3):283-91. doi: 10.1016/0167-4781(93)90215-y.
7
Transcription and DNA supercoiling.转录与DNA超螺旋
Curr Opin Genet Dev. 1993 Oct;3(5):764-8. doi: 10.1016/s0959-437x(05)80096-6.
8
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.相关的20K调节亚基在体内对细胞周期蛋白依赖性激酶2(CDK2)活性的抑制作用。
Nature. 1993 Dec 16;366(6456):707-10. doi: 10.1038/366707a0.
9
p21 is a universal inhibitor of cyclin kinases.p21是细胞周期蛋白激酶的通用抑制剂。
Nature. 1993 Dec 16;366(6456):701-4. doi: 10.1038/366701a0.
10
WAF1, a potential mediator of p53 tumor suppression.WAF1,一种p53肿瘤抑制的潜在介导因子。
Cell. 1993 Nov 19;75(4):817-25. doi: 10.1016/0092-8674(93)90500-p.